期刊档案 · 工程技术-工程:生物医学

Biomedical Signal Processing and Control

ISSN 1746-8094 · eISSN 1746-8108 · Elsevier BV · ENGLAND · Quarterly · 创刊 2006

Biomedical Signal Processing and Control 中科院 医学 2区(2025 年升级版),影响因子 5.65,混合开放获取,APC 约 2,590 美元,出版商公布投稿到接收约 203 天,录用比例容易(社区反馈),2025 年发文 1,861 篇,SCIE、Scopus 收录。

影响因子5.65LetPub 汇总的最新公布值
中科院分区医学 2区2025 年升级版大类 · 2026 新锐版 医学 2区
审稿周期203 天出版商公布的投稿到接收时间 · 社区反馈约 3 个月
版面费2,590 USD混合期刊,仅开放获取发表时收取
录用比例容易投稿社区平均反馈
年发文量1,861 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Biomedical Signal Processing and Control 由 Elsevier BV 出版,属中科院医学大类(2025 升级版2区)。按 OpenAlex 近年发文统计,该刊主要发表 EEG and Brain-Computer Interfaces、AI in cancer detection、ECG Monitoring and Analysis 等主题的论文,这 3 个主题约占 30.2%。(根据 OpenAlex 主题统计与中科院分区数据生成)

The Journal of Biomedical Signal Processing and Control (BSPC), the Official Journal of the European Alliance of Medical and Biological Engineering and Science (EAMBES), publishes original, high-quality research that advances the theory, methodology, and application of signal and data processing techniques for understanding, modelling, and improving human health. The journal provides an interdisciplinary platform at the intersection of engineering, data science, and medicine, with a focus on extracting meaningful physiological, pathological, and behavioural information from biomedical signals, images, and related data.BSPC welcomes contributions that develop novel methods for signal and image acquisition, processing, analysis, modelling, and interpretation, as well as clinically validated applications. Emphasis is placed on approaches that address real-world challenges such as noise, non-stationarity, high dimensionality, multimodality, personalization, real-time operation, and interpretability, and that demonstrate clear translational relevance to healthcare, diagnostics, therapeutics, rehabilitation, and biomedical research.A defining characteristic of BSPC is its emphasis not only on the analysis of biomedical signals and medical images, but also on how these data are used to drive decisions, feedback mechanisms, and closed-loop control in medical devices, digital health technologies, and clinical systems.Scope of the JournalThe scope includes—but is not limited to—the following topics:Processing and analysis of biomedical signals such as EEG, ECG, EMG, EOG, MEG, PPG, respiratory signals, blood pressure, neural recordings, and biosensor dataMedical image processing and analysis, and integration of imaging with physiological signalsMultimodal and multiscale signal processing and data fusionMachine learning, deep learning, and statistical methods for biomedical signal and image analysisTime–frequency, adaptive, nonlinear, and data-driven signal processing methodsBrain–computer interfaces, neurotechnology, and neurophysiological systemsWearable, implantable, mobile, and remote health monitoring systemsPhysiological modelling, digital biomarkers, and data-driven health analyticsSignal quality assessment, artifact detection, denoising, and robustness analysisPersonalized and precision medicine enabled by signal and data analyticsReal-time systems, embedded implementations, and clinical or translational validationClosed-loop and feedback-controlled biomedical systems, including therapeutic and assistive devicesThe journal encourages submissions ranging from theoretical advances and algorithmic innovations to experimental studies, clinical investigations, prototype systems, and benchmark or dataset papers. By fostering collaboration across disciplines, Biomedical Signal Processing and Control aims to accelerate the development of robust, interpretable, and clinically impactful signal- and data-driven solutions for modern healthcare.

摘自期刊官网 Aims & Scope

研究方向(LetPub):工程技术-工程:生物医学

主编 Panicos A. Kyriacou出版商官网

编委会国家分布:中国大陆 20 位(约 27%);主要国家 中国 20、意大利 19、英国 13、美国 4、澳大利亚 3(共 74 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. EEG and Brain-Computer InterfacesNeuroscience14.1%
  2. AI in cancer detectionComputer Science8.4%
  3. ECG Monitoring and AnalysisMedicine7.7%
  4. Brain Tumor Detection and ClassificationNeuroscience5.4%
  5. Non-Invasive Vital Sign MonitoringEngineering5.4%
  6. Advanced Neural Network ApplicationsComputer Science5.2%
  7. Medical Image Segmentation TechniquesComputer Science5.1%
  8. Radiomics and Machine Learning in Medical ImagingMedicine4.4%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)医学 2 区
类别学科分区
大类医学2 区
小类工程:生物医学ENGINEERING, BIOMEDICAL3 区

Top 期刊:否综述期刊:否

《新锐期刊分区表》( 2026年3月发布)医学 2 区
类别学科分区
大类医学2 区
小类工程:生物医学ENGINEERING, BIOMEDICAL2 区

Top 期刊:是综述期刊:未标注

期刊分区表( 2023年12月旧的升级版)医学 2 区
类别学科分区
大类医学2 区
小类工程:生物医学ENGINEERING, BIOMEDICAL3 区

Top 期刊:否综述期刊:否

数据库收录

SCIEScopusLetPub

国际期刊预警名单:各版本均未列入LetPub

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子
5.65LetPub ·
影响因子(出版商公布)
5.7出版商官网 ·
CiteScore 2026-06
13LetPub ·
CiteScore(出版商公布)
13出版商官网 ·
SJR 2026-06
1.34LetPub ·
SNIP 2026-06
1.74LetPub ·
h-index
51LetPub ·
h-index
154OpenAlex ·
i10-index
4,675OpenAlex ·
两年平均被引
5.03OpenAlex ·
自引率
12.3%LetPub ·
Gold OA 文章占比
14.32%LetPub ·

发文规模

年文章数
1,781LetPub ·

逐年发文量 OpenAlex 统计 · 累计 10,591 篇 · 当年数据不完整

年份发文量其中 OA被引
20261,939558794
20251,8613207,326
20241,39827118,001
20231,23323326,486
202291915024,979
20211,00222432,283

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

出版商公布的审稿周期 期刊官网自述数据

203 天投稿到接收 · 投稿社区反馈约 3 个月

出版商统计口径以官网为准;本刊近 24 个月的文章日期尚未获得,因此以官方数据为准。

各来源数据

平均审稿速度(社区反馈)
平均3.0个月LetPub ·
平均录用比例(社区反馈)
容易LetPub ·
投稿到首次决定
10 天出版商官网 ·
外审后首次决定
66 天出版商官网 ·
投稿到接收
203 天出版商官网 ·
接收到发表
12 天出版商官网 ·
评审方式
单盲同行评审出版商官网

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

混合开放获取LetPub

订阅期刊,作者可付费选择开放获取发表。

来源文章处理费费用减免许可证观测时间
OpenAlexUSD 2,590 / EUR 2,420 / GBP 2,070 / JPY 321,240——
出版商官网USD 3,470——

混合期刊的文章处理费仅在作者选择开放获取发表时收取;按订阅方式发表通常不收费。

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

投稿准备要点3 项,摘自作者指南
摘要
≤ 250 词
关键词
1–7 个
Highlights(研究亮点)
必须提供
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型11 种,含篇幅限制
  1. full paper•Reviews, 10,000 words. We would like to increase the number of reviews published and so potential authors are actively encouraged to contact the Editor-in-Chie…未说明篇幅
  2. full papersFull papers, describing original work, i.e. the technical development and the clinical / experimental study to prove the concept / value of a novel technique an…未说明篇幅
  3. perspective•Reviews, 10,000 words. We would like to increase the number of reviews published and so potential authors are actively encouraged to contact the Editor-in-Chie…未说明篇幅
  4. review•Reviews, 10,000 words. We would like to increase the number of reviews published and so potential authors are actively encouraged to contact the Editor-in-Chie…正文 ≤ 10,000 词
  5. review article•Reviews, 10,000 words. We would like to increase the number of reviews published and so potential authors are actively encouraged to contact the Editor-in-Chie…未说明篇幅
  6. reviewsReviews, 10,000 words. We would like to increase the number of reviews published and so potential authors are actively encouraged to contact the Editor-in-Chief…未说明篇幅
  7. short communication•Reviews, 10,000 words. We would like to increase the number of reviews published and so potential authors are actively encouraged to contact the Editor-in-Chie…正文 ≤ 2,000 词
  8. short communicationsShort communications, typically 2,000 words. These manuscripts report important observations that are usually preliminary in nature.未说明篇幅
  9. short review•Reviews, 10,000 words. We would like to increase the number of reviews published and so potential authors are actively encouraged to contact the Editor-in-Chie…未说明篇幅
  10. technical note•Reviews, 10,000 words. We would like to increase the number of reviews published and so potential authors are actively encouraged to contact the Editor-in-Chie…未说明篇幅
  11. technical notesTechnical Notes should normally describe a technical development (could be a software package for example) and would not normally look at data from a large coho…未说明篇幅
出版商官网
官网政策摘录AI 使用、作者资格、利益冲突、许可与版权、开放获取、同行评审、预印本
AI 使用 Declaration of generative AI use

作者在提交论文时必须声明在稿件准备过程中使用生成式AI工具的情况;AI工具只能在人类监督和控制下使用,绝不能替代人类的批判性思维、专业知识和评估。 模型中文摘要

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

原文 ↗出版商官网 ·
作者资格 Group authorship

团体署名指将文章归属于一个有明确定义和命名的作者团体,其成员对该工作有贡献;团体署名必须在提交时在标题页声明,提交作者应在提交系统的“Collaborative Author Groups”下填写该团体。 模型中文摘要

Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…

原文 ↗出版商官网 ·
利益冲突 Declaration of competing interests

所有作者必须披露可能不当影响或偏倚其工作的与他人或组织的财务和个人关系,包括雇佣、咨询、持股、酬金、付费专家证言、专利申请或注册、资助等;必须始终完成声明工具,有期刊隶属关系的作者应在声明工具的“Other Activities”下填写指定文本。 模型中文摘要

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …

原文 ↗出版商官网 ·
许可与版权 License options

作者将获得开放获取用户许可选项,这些选项决定作者本人和第三方如何复用其开放获取文章;建议在选择许可选项前审查这些选项以及资助机构的许可要求。 模型中文摘要

Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.

原文 ↗出版商官网 ·
开放获取 Open access

该期刊引导作者参阅其开放获取信息页面,以了解该期刊的开放获取选项。 模型中文摘要

We refer you to our open access information page to learn about open access options for this journal.

原文 ↗出版商官网 ·
同行评审 Peer review

该期刊采用单盲同行评审流程;提交的稿件先由编辑评估,若被认为合适,通常会送至少两名审稿人进行独立专家评估;接受或拒绝的决定由编辑作出;编辑不参与涉及自身、家人或同事、或与其有利益关系的论文的决策。 模型中文摘要

This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…

原文 ↗出版商官网 ·
预印本 Preprints

作者可按照Elsevier的文章共享政策分享预印本,分享预印本(如在预印本服务器上)不计作先前发表;该期刊支持开放科学,在SSRN上提供免费的预印本发布服务,投稿时可选择将稿件发布到SSRN,通过期刊初步桌面评审后即公开可用。 模型中文摘要

Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Elsevier BV
出版国家或地区
ENGLAND
出版语言
English
出版周期
Quarterly
创刊年份
2006
ISSN
1746-8094
电子版 ISSN
1746-8108
学会 / 主办单位
European Alliance of Medical and Biological Engineering and Science
官方链接

常见问题

关于 Biomedical Signal Processing and Control 的常见问题

Biomedical Signal Processing and Control 是中科院几区期刊?

2025 年升级版分区表中,Biomedical Signal Processing and Control 为医学 2区,小类 工程:生物医学 3 区。2026 年新锐版分区表中为医学 2区。不同版本与大小类分区不能混用。

Biomedical Signal Processing and Control 的影响因子是多少?

LetPub 汇总的最新公布影响因子为 5.65,CiteScore 为 13,h-index 为 154。

Biomedical Signal Processing and Control 的审稿周期多长?

出版商公布的投稿到接收时间约为 203 天;投稿社区反馈的平均审稿速度为约 3 个月,平均录用比例反馈为“容易”。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Biomedical Signal Processing and Control 的投稿格式要求是什么?

据期刊作者指南:摘要:≤ 250 词;关键词:1–7 个;Highlights:必须提供。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。

Biomedical Signal Processing and Control 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 74 位编委中,中国大陆 20 位(约 27%);人数最多的国家是 中国(20 位)、意大利(19 位)、英国(13 位)。统计按编委会页面列出的机构国家计,仅供参考。

Biomedical Signal Processing and Control 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Biomedical Signal Processing and Control 被 SCIE、Scopus 收录。

Biomedical Signal Processing and Control 是开放获取期刊吗?版面费多少?

Biomedical Signal Processing and Control 为混合开放获取。选择开放获取发表时APC 约 2,590 美元。

来源与更新

本页事实来自 LetPub、出版商官网、OpenAlex;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-25 归档)。最近更新:。